Royalty Report: Drugs, Biotechnology, Diagnostic Substances – Collection: 1821


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 4


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4

Primary Industries

  • Drugs
  • Biotechnology
  • Diagnostic Substances
  • Diagnostic
  • Medical
  • Device
  • Disease

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 1821

License Grant
The Licensee was granted a non-transferable and non-exclusive license by Netherlands Licensor under the patent rights, Sol Particle Immuno Assay.
Field of Use
In the field of use related to rapid testing, utilizing colloidal gold markers, in the field of diagnostics.

IPSCIO Record ID: 4624

License Grant
Licensor grants to Licensee an exclusive license to the Licensed Technology on a royalty-bearing basis, including the exclusive right to grant sublicenses, for revenue-generating Authorized Uses in the Field of Use in the Licensed Territory. Licensee may not sell Licensed Technology to a third-party or seek patent protection for Licensed Technology.
License Property
Licensor owns certain rights, title, and interest in and to the Licensed Technology (as defined herein), as follows

1. DxStrip HIV-1 and HIV-2, Rapid Test for HIV-1 and HIV-2, Catalogue # DSH3CS204, for in-vitro diagnostic use only.

2. AccuSpotâ„¢ Dengue Fever, Rapid Test for Dengue Fever IgM and IgG, Catalogue #ASDF-CS201, for in-vitro diagnostic use only.

3. Trade Secrets/Know-how/manufacturing support – Colloidal Gold Suspension /Colloidal Gold custom manufacturing business

'Licensed Technology' shall mean (i) DxStrip HIV-1 and HIV-2, Rapid Test for HIV1 and HIV-2, Catalogue # DSH3CS204; (ii) AccuSpotâ„¢ Dengue Fever, Rapid Test for Dengue Fever IgM and IgG, Catalogue #ASDF-CS201; and (iii) Trade Secrets/Know how/manufacturing support – Colloidal Gold Suspension /Colloidal Gold custom manufacturing business.

IPSCIO Record ID: 2219

License Grant
The Company hereby grants a non-exclusive, non-transferable right and license under the Licensed Patents, without the right to sublicense, to make, have made for its own use and sale, use, offer for sale, sell, and import Product and to practice the methods claimed in the Licensed Patents in connection with such Product, and to extend to its customers purchasing Product the right to use and sell the Product purchased and to practice the methods claimed in the Licensed Patents in connection with such Product, all of the foregoing limited expressly to the field of human in vitro manually formatted immunodiagnostic assays.
License Property
Product shall mean immunodiagnostic assays.

Licensed Patent(s) shall mean United States Letters Patent No. 5,591,645. Patents relate to Rapid Manual Tests for hCG and LH analytes.  Human chorionic gonadotropin or human chorionic gonadotropin (hCG) is a glycoprotein hormone produced in pregnancy that is made by the developing embryo after conception and later by the syncytiotrophoblast (part of the placenta).

Field of Use
Field of Use shall mean human.

IPSCIO Record ID: 2603

License Grant
The Netherlands Company hereby grants to Licensee a non-transferable, non-exclusive license, without the right to sublicense, to use the NASBA Technology and/or the Boom Technology and/or the Patent Rights for the sole purpose of manufacturing, using, selling and/or having sold by independent resellers Licensed Products under its own label or the label of an Affiliated Company in the Clinical Diagnostic Testing in the Field of Use in the Territory for the life of this Agreement.
License Property
The term NASBA means isothermal transcription based enzymatic nucleic acid amplification procedure, method or system.

The term Licensed Products shall mean any in vitro diagnostic test, assay, method or kit, the development, manufacture, use or sale of which make use of the NASBA Technology, the Boom Technology and / or the NASBA and Boom Technology and are covered by one or more claims of the Patent rights.

Field of Use
The Field of Use shall mean clinical diagnostic tests for detection of pathogens for HIV, Hepatitis and other sexually transmitted diseases in human subjects.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.